Promises and Challenges of Immunogenic Chemotherapy in Multiple Myeloma

Promises and Challenges of Immunogenic Chemotherapy in Multiple Myeloma

Immunological tolerance of myeloma cells represents a critical obstacle in achieving long-term disease-free survival for multiple myeloma (MM) patients. Over the past two decades, remarkable preclinical efforts to understand MM biology have led to the clinical approval of several targeted and immuno...

Full description

Bibliographic Details
Main Authors: Megan Johnstone, Delaney Vinaixa, Marcello Turi, Eugenio Morelli, Kenneth Carl Anderson, Annamaria Gulla
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Cells
Subjects:
myeloma
ICD
immunogenic chemotherapy
DAMPs
microenvironment
Online Access:https://www.mdpi.com/2073-4409/11/16/2519

Internet

https://www.mdpi.com/2073-4409/11/16/2519

Similar Items